Results 191 to 200 of about 12,661 (240)
Some of the next articles are maybe not open access.

Bispecific Antibodies to PD-1 and CTLA4: Doubling Down on T Cells to Decouple Efficacy from Toxicity.

Cancer Discovery, 2021
Although combination anti-PD-1 and anti-CTLA4 mAbs have revolutionized outcomes for many cancers, their utility has been limited due to significant immune-related toxicities and the emergence of resistance.
E. Burton, H. Tawbi
semanticscholar   +1 more source

[CTLA4-Ig (abatacept)].

Nihon rinsho. Japanese journal of clinical medicine, 2007
Although tumor necrosis factor (TNF) antagonists have dramatically improved the outcome of patients with rheumatoid arthritis (RA), some of the patients do not respond or cannot tolerate these drugs. Abatacept is a recombinant fusion protein containing components of IgG and cytotoxic T-lymphocyte-associated antigen-4 that inhibit costimulatory signal ...
openaire   +1 more source

???????????? ???????????????????? ???????????????????????? 49A/G ???????? CTLA4 ?? ?????????????????? ???????????????????????????? ????????????

2014
Polymorphism of 49A/G gene CTLA4 in 44 patients with allergic rhinitis and 70 conditioned healthy donors of Uzbek population has been analyzed. The ??unfavourable allele?? rate in general studied groups and control groups did not practically differ and was 73,3 and 72,9 % correspondingly.
openaire   +1 more source

Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart

Nature Reviews. Cancer
Amir Z. Munir   +4 more
semanticscholar   +1 more source

CTLA4-Ig

Reactions Weekly, 2008
openaire   +1 more source

Identification of an immune overdrive high-risk subpopulation with aberrant expression of FOXP3 and CTLA4 in colorectal cancer

Oncogene, 2021
Kai-Sa Cui   +8 more
semanticscholar   +1 more source

CTLA4 in multiple sclerosis.

Journal of the Neurological Sciences, 2001
H.B Rasmussen   +3 more
openaire   +1 more source

CTLA4-Ig

2014
Ronald L. George, E. William St. Clair
openaire   +1 more source

Home - About - Disclaimer - Privacy